12th European Breast Cancer Conference (EBCC-12 Virtual)

02 October 2020 - 03 October 2020

Complete response to neoadjuvant treatment improves survival in early breast cancer

12 Nov 2020 by

Women with HER2+ early breast cancer who achieved pathologic complete response (pCR) on neoadjuvant treatment had improved overall survival (OS) and event-free survival (EFS) outcomes, according to final analysis results of the phase III NeoALTTO, BIG 1-06 trial.

Complete response to neoadjuvant treatment improves survival in early breast cancer

12 Nov 2020

Pre-radiotherapy CT scan may help identify CVD risk in women with breast cancer

11 Nov 2020 by

The use of an algorithm to identify the presence of coronary artery calcifications (CAC) during radiotherapy-planning CT scans may help assess cardiovascular disease (CVD) risk in women with breast cancer, according to a study from the Netherlands.

Pre-radiotherapy CT scan may help identify CVD risk in women with breast cancer

11 Nov 2020

Incident, proliferative benign breast disease tied to greatest breast cancer risk

30 Oct 2020 by

Women with incident, proliferative benign breast diseases (BBDs) may have an elevated risk of developing breast cancer, according to a retrospective study conducted in Spain.

Incident, proliferative benign breast disease tied to greatest breast cancer risk

30 Oct 2020